However, in a subset of multiple myeloma cells, where DEPTOR was overexpressed, DEPTOR acts as an oncogene and survival factor, since DEPTOR inhibition of mTORC1 relieves the feedback inhibition from S6K1 to PI3K, boosting AKT activity for cancer cells survival [1, 2, 5]. Here, DEPTOR is linked to plasma cell myeloma.